Are vancomycin dosing guidelines followed? A mixed methods study of vancomycin prescribing practices-Reference-Cited by-同舟云学术

Are vancomycin dosing guidelines followed? A mixed methods study of vancomycin prescribing practices

Published:2021-04-14 Issue:11 Volume:87 Page:4221-4229
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Carland Jane E.¹²³^ORCID,Stocker Sophie L.¹²⁴^ORCID,Baysari Melissa T.⁵^ORCID,Li Crystal¹⁶,Själin Jacqueline¹⁷,Moran Maria A.¹,Tang Sarah¹⁸,Sandaradura Indy⁹¹⁰^ORCID,Elhage Tania¹⁶,Gilbey Timothy¹¹,Williams Kenneth M.¹⁶,Marriott Deborah J. E.²¹¹^ORCID,Day Richard O.¹²^ORCID

Affiliation:

1. Department of Clinical Pharmacology and Toxicology St Vincent's Hospital Darlinghurst NSW Australia

2. St Vincent's Clinical School University of NSW Kensington NSW Australia

3. Department of Pharmacology, School of Medical Sciences University of NSW Kensington NSW Australia

4. Sydney Pharmacy School, Faculty of Medicine and Health The University of Sydney NSW Australia

5. Sydney School of Health Sciences, Charles Perkins Centre, Faculty of Medicine and Health The University of Sydney NSW Australia

6. School of Medical Sciences University of NSW Kensington NSW Australia

7. Department of Medicine Karolinska Institute Stockholm Sweden

8. Pharmacy Department Singapore General Hospital Singapore Singapore

9. Centre for Infectious Diseases and Clinical Microbiology, Westmead Hospital Westmead NSW Australia

10. Sydney School of Medical Sciences, Faculty of Medicine and Health The University of Sydney NSW Australia

11. Department of Clinical Microbiology and Infectious Diseases St Vincent's Hospital Darlinghurst NSW Australia

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bcp.14834

Reference45 articles.

1. Executive summary: therapeutic monitoring of vancomycin for serious methicillin‐resistant Staphylococcus aureus infections: a revised consensus guideline and review of the American Society of Health‐System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists;Rybak MJ;J Pediatric Infect Dis Soc,2020

2. Clinical pharmacist impact on care, length of stay, and cost in pediatric cystic fibrosis (CF) patients

3. Therapeutic monitoring of vancomycin in adult patients: A consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists

4. Therapeutic monitoring of vancomycin for serious methicillin‐resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health‐system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists;Rybak MJ;Clin Infect Dis,2020

5. The dosing and monitoring of vancomycin: what is the best way forward?

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Economic evaluations of therapeutic drug monitoring interventions in acute hospital‐based settings: A systematic review;British Journal of Clinical Pharmacology;2024-07-10

2. Optimizing vancomycin therapeutic drug monitoring compliance in pediatric oncology: towards personalized medication management;Personalized Medicine;2024-07-03

3. Developing an intervention package to optimise the management of vancomycin therapy using theory informed co-design;Research in Social and Administrative Pharmacy;2024-05

4. The Influence of a Therapeutic Drug Monitoring Service on Vancomycin‐Associated Nephrotoxicity;The Journal of Clinical Pharmacology;2023-10-25

5. Evaluation Of Vancomycin Therapeutic Drug Monitoring in Intensive Care Units of a University Hospital;Cukurova Anestezi ve Cerrahi Bilimler Dergisi;2023-08-31